<DOC>
	<DOCNO>NCT01382043</DOCNO>
	<brief_summary>The safety efficacy drug-eluting stent ( DES ) biocompatible polymer demonstrate randomized clinical trial well real world practice . Theoretically , new DES biodegradable polymer reduce incidence late in-stent thrombosis , however , long-term safety efficacy stent remain unknown . This study aim compare safety efficacy Excel DES biodegradable polymer Endeavor DES biocompatible polymer individual .</brief_summary>
	<brief_title>Angiographic IVUS Follow-up After Simultaneously Implanted Different Drug-eluting Stents Same Individuals ( AIFSIDDES )</brief_title>
	<detailed_description />
	<criteria>simultaneous implantation one Endeavor stents one Excel stents index procedure willing follow coronary angiography intravascular ultrasound least one year postprocedure . Patients exclude study two kind stent implant two study stent implant separate interventional procedure coronary artery bridge vessel restenotic lesion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>percutaneous coronary angioplasty</keyword>
	<keyword>zotarolimus-eluting stent</keyword>
	<keyword>sirolimus-eluting stent</keyword>
	<keyword>biodegradable polymer</keyword>
	<keyword>biocompatible polymer</keyword>
</DOC>